Medicine Department Articles & Analysis
21 news found
Tune into this episode of HF Beat to hear our co-hosts interview Paul Heidenreich, MD, FHFSA, a co-author of the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure about economic considerations in the management of HF. On "From Failure to Function", Priya dives into the late breaking trials from ACC.23 and Michael reviews three papers on HFpEF on HF Rounds. ...
Aditya Bardia, MD, MPH, Director of Breast Cancer Research at Mass General Cancer Center, Associate Professor at the Medicine Department at Harvard Medical School, and Principal Investigator for the EMERALD trial. ...
Marianna University School of Medicine, Department of Respiratory Medicine, Kawasaki, Japan. “Many patients with advanced disease continue to struggle to breathe, making even simple daily tasks difficult. ...
Details for the oral presentation are as follows: Title: Pemvidutide (ALT-801), a novel GLP-1/Glucagon Dual Receptor Agonist, Achieves Rapid and Potent Reductions in Body Weight and Liver Fat: Results of a Placebo-Controlled, Double-Blind, First-in-Human (FIH) Clinical Trial Presenter: Stephen Harrison, M.D., Visiting Professor of Hepatology, Radcliffe Department of ...
Rocky Vista University (RVU) celebrated the graduation of 154 medical students from its College of Osteopathic Medicine (COM) and 37 graduate students from its Master of Science in Biomedical Sciences (MSBS) program on the Colorado campus. ...
From 2012 through 2017 James held an appointment as Lecturer at Stanford University in the Department of Medicine, Division of Clinical Pharmacology in the School of Medicine. ...
Sewall Professor, Stanford University School of Medicine, Department of Otolaryngology – Head & Neck Surgery and Institute for Stem Cell Biology and Regenerative Medicine ISCBRM. ...
The results showed that there is a lack of agreement between PAP and blood volume metrics, confirming that the two variables should be thought of as independent variables for physicians to target. Marat Fudim, M.D., Department of Medicine, Duke University Hospital, lead author of the study, concluded, “These findings indicate that pressure-based assessment ...
She graduated from the Chemistry Department, University of Athens in 2001 and received her PhD at the University of Heidelberg in Germany in 2006. ...
In combination with background immunosuppressive therapy, LUPKYNIS is the first and only FDA-approved medicine with three years of pivotal trial results, including long-term safety data, within LN. “Up to half of patients with systemic lupus erythematosus will develop lupus nephritis, that can result in severe and permanent damage to the kidneys and, in some cases, renal ...
Lehan Chair in Cardiovascular Research, and professor and chairman of the department of medicine at the University of Mississippi Medical Center. ...
ByBayer AG
“In this updated interim analysis, reductions in proteinuria were sustained with no impact on renal function at a total of 30 months of treatment with voclosporin,” said Amit Saxena, M.D., assistant professor, department of medicine at NYU Langone Medical Center and presenting author of the AURORA 2 study. ...
“I have witnessed the advances of medicine in the past decades beneficial to mankind through my career in medicine and national health department. ...
In a separate instance, in a collaborative effort with the UMBC Sports Medicine Department, a test conducted in a team locker room resulted in a positive environmental detection on the BioFlash. ...
“Daxor submitted an excellent proposal to our most recent call for applications and rose to the top of a very competitive field,” said David McManus, Co-Principal Investigator of CAPCaT and Professor and Chair of the Department of Medicine at UMass Medical School. “We look forward to working with them to advance their product toward the ...
” The Abstract was authored by Stephen Davis and his team at University of Miami Miller School of Medicine, Department of Dermatology & Cutaneous Surgery, with assistance from Robin Martin PhD Scientific Consulting. ...
I am happy that the FDA has approved an IDE for this study that will evaluate a new approach to T2D that can potentially improve glycemic control and reduce insulin needs,” said endocrinologist David Klonoff, M.D., Clinical Professor of Medicine, University of California, San Francisco. “I am excited to partner with my endocrine colleagues in evaluating the role of ...
By using the resources of both the company and through collaboration with the Nuffield Department of Medicine, OVM will contribute its ROP technology to the global effort being made to defeat Covid-19. ...
Throughout the month, Thermo Fisher will promote sepsis awareness through our Twitter (@fishersci, @thermofisher), Facebook (@fisherscientific, (@thermofisher) and LinkedIn (@thermo-fisher-scientific, @fisher-healthcare) accounts, participate in community conversations (#SAM2019, #antibioticstewardship, #sepsisawareness and #sepsis), and will host or support several educational events: ...
Robert Ohgami, of Stanford University School of Medicine's Department of Pathology. "We rely heavily on SureCall to analyze sequencing data in our hematologic myeloid neoplasms studies. ...